Nanomedicine News

RSS

Future Lab-on-a-Chip Uses Nanoscale Electrical Fields to Detect and Manipulate Cells and Biomolecules

Tracking down cancer at a very early stage, studying cell growth, developing new medicines: future lab-on-a-chip systems will use nanoscale electrical fields to enable the detection and manipulation of cells and biomolec...

19 Aug 2008

Start-Up Companies Receives Financial Boost to Advance Their Nanotechnology Research

Two start-up companies spun out of UniQuest, The University of Queensland's main commercialisation company, have received a financial boost to advance their research priorities. Uniseed Management Pty Ltd, which ...

18 Aug 2008

Synthetic Molecules Able to Kill Cancer Cells and Stopping it from Spreading

Seeking to improve on nature, scientists used a spice-based compound as a starting point and developed synthetic molecules that, in lab settings, are able to kill cancer cells and stop the cells from spreading. The re...

18 Aug 2008

Accelerator Corp Takes Nanogen License to Create Novel Therapeutics

Accelerator Corporation, a privately–held biotechnology investment and development company today announced the formation of a new company, Mirina Corporation, focused on developing therapeutics using Minor Groove B...

From Nanogen 16 Aug 2008

SlideCollector 48 from Carl Zeiss Ensures Highest Levels of Sample Purity

One of the major problems inherent in the expression analysis of single cells is the large amount of sample handling involved and the subsequent high risk of contamination as cells isolated and harvested using laser microdissection are manually transferred to an assay plate for expression analysis. Until now, the only way to safeguard that the genetic data collected was from cells of interest and not from surrounding tissue has been to perform numerous repeat experiments.

From Carl Zeiss Microscopy GmbH 16 Aug 2008

Nanoparticles and Collagen Mimetic Peptides Producing Detailed Images of Tumors

When used with nanoparticles, this molecule, called collagen mimetic peptide (CMP) could produce detailed images of tumors, detect deadly buildup in arteries, deliver drugs, and improve blood supply to implanted tissues.

16 Aug 2008

Still Much to Learn About this Small Scale Science

Anyone interested in nanobiotechnology can confirm there’s still much to learn about this small scale science. Few know this better than the more than 30 students and fellows participating in nanobiotechnology rela...

16 Aug 2008

Dual-Modality Machines Simultaneously Perform Two Different Types of Scans

Medical imaging represents one of the most used and useful procedures in the oncologist’s diagnostic toolkit, even though each of the most useful techniques—magnetic resonance imaging (MRI), computerized tomo...

16 Aug 2008

Using Targeted Carbon Nanotubes as Delivery Agents

Platinum-based anticancer agents have a long history as proven therapeutic agents, but their toxicity and short lifetime in the body and the ability of tumors to develop resistance to these drugs limit the ultimate utili...

16 Aug 2008

First Experimental Measurements of Mechanical Properties of Carbon Nanotubes

For more than 15 years, carbon nanotubes (CNTs) have been the flagship material of nanotechnology. Researchers have conceived applications for nanotubes ranging from microelectronic devices to cancer therapy. Their atomi...

16 Aug 2008